Tarsus Pharmaceuticals, Inc. (TARS)
65.37
-0.54
(-0.82%)
USD |
NASDAQ |
Feb 11, 16:00
65.37
0.00 (0.00%)
After-Hours: 16:47
Tarsus Pharmaceuticals Shareholders Equity (Quarterly) : 335.08M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 6.057B |
| Precigen, Inc. | 41.87M |
| Celcuity, Inc. | 116.96M |
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| Agenus, Inc. | -274.14M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 534.56M |
| Total Liabilities (Quarterly) | 199.48M |
| Debt to Equity Ratio | 0.2462 |
| Current Ratio | 4.286 |
| Net Debt Paydown Yield | -0.08% |